Ticlid seems to increase the risk of another potentially fatal blood disorder

May 1998

Ticlid seems to increase the risk of another potentially fatalblood disorder...thrombotic thrombocytopenic purpura (TTP).

Ticlid patients are already being monitored for neutropenia...now there are at least 60 reports of TTP.

TTP leads to thrombocytopenia...anemia...renal dysfunction...and neurologic changes that can be confused with a stroke. About 30%of these patients die.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

tamoxifen (Nolvadex) to PREVENT breast cancer
Renal Urology new impotence drug, Viagra (sildenafil)
Renal Urology Detrol (tolterodine) for urinary frequency, urgency, or urge incontinence
Cardiology whether more patients with heart failure should get warfarin
Cardiology Ticlid seems to increase the risk of another potentially fatal blood disorder
Diabetes Prandin (repaglinide), a new oral hypoglycemic for type 2 diabetes
recommending vitamin and mineral supplements
Lice unusual head lice treatments
Cholesterol Pravachol (pravastatin) and Zocor (simvastatin) are now approved to prevent STROKE
Cholesterol liver function tests can be done less frequently for patients taking statins
Cholesterol Tricor (fenofibrate) for patients with high triglycerides (TGs)
Ophthalmology several new prescription eye drops for allergies and inflammation
Parkinson s Disease changes in the treatment of Parkinson's
attention on adverse drug reactions
Cardiology higher doses of ACE inhibitors

Ticlid seems to increase the risk of another potentially fatal blood disorder

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents